1. Home
  2. Category
  3. Treatment Types

Chemotherapy

Online Exclusive Article

Intraperitoneal Chemotherapy: The Lived Experiences of Taiwanese Patients With Ovarian Cancer

Ju-Fen Chou
Yu Ying Lu
CJON 2019, 23(6), E100-E106 DOI: 10.1188/19.CJON.E100-E106
Background: Intraperitoneal (IP) chemotherapy is often a preferred treatment for ovarian cancer because of its clinical benefits, but research on the experiences of patients receiving IP chemotherapy is limited. Objectives: The purpose of this article is to explore the lived experiences of...
0
No votes yet
Read this Article
Article

Nursing Assistants’ Use of Personal Protective Equipment Regarding Contact With Excreta Contaminated With Antineoplastic Drugs

AnnMarie L. Walton
Shawn Kneipp
Laura Linnan
Josephine Asafu-Adjei
Christian Douglas
Maija Leff
Bonnie Rogers
ONF 2019, 46(6), 689-700 DOI: 10.1188/19.ONF.689-700
Purpose: To examine the feasibility of observing and interviewing nursing assistants about handling of antineoplastic drugs contaminated with excreta, acceptability of a measure of personal protective equipment (PPE) use with nursing assistants, and predictors of PPE use. Participants & Setting...
0
No votes yet
Read this Article
Article

Exploring Nurses’ Understanding of Anticipatory Nausea and Vomiting in Patients With Cancer

Anne Ryan
Brendan Noonan
ONF 2019, 46(6), 738-745 DOI: 10.1188/19.ONF.738-745
Purpose: To explore nurses’ self-reported understanding of anticipatory nausea and vomiting (ANV) in patients with cancer. Participants & Setting: 12 oncology RNs were recruited from University Hospital Limerick in Ireland. Methodologic Approach: Data were collected via semistructured...
0
No votes yet
Read this Article
Article

Rituximab: A New Monoclonal Antibody Therapy for Non-Hodgkin's Lymphoma

Cheryl D. Kosits
Mary Callaghan
ONF 2000, 27(1), 51-59 DOI: 10.1188/00.ONF.51-59
Purpose/Objectives: To review the use of monoclonal antibodies (MAbs), specifically rituximab, in the treatment of non-Hodgkin's lymphoma (NHL) and to describe the nursing management of patients receiving rituximab. Data Sources: Published articles, abstracts, book chapters, drug manufacturer,...
0
No votes yet
Read this Article
Quality & Safety

5-Fluorouracil Infiltrations and Ambulatory Pumps: Education, Prevention, and Management Considerations

Chelsea Bostelman
CJON 2019, 23(5), 537-539 DOI: 10.1188/19.CJON.537-539
Although uncommon, 5-fluorouracil (5-FU) infiltrations do occur. Two case studies involving 5-FU infiltration from totally implanted venous access devices identified at the conclusion of a 46-hour continuous infusion via an ambulatory infusion pump are presented. These cases highlight the...
0
No votes yet
Read this Article

Related e-Books

View More

Questions, Concerns or Requests

We're just a click away for assistance.